Precision diagnosis and treatment study for liver cancer
Part of Cancer, Digestive system clinical trials.
This study aims to improve how doctors diagnose and treat liver cancer by combining advanced imaging tests and genetic analysis. It may help in choosing the most effective treatment for each person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You must have been diagnosed with either hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (ICC), two types of liver cancer.
- You must be scheduled to have surgery or conversion therapy (treatment to make surgery possible).
- The liver tumor must be confirmed by a biopsy or after surgery.
- The tumor must be located no deeper than 8 cm (about 3 inches) from the skin surface.
- You must be able to hold your breath during imaging exams.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special, high-detail ultrasound to get clearer images of liver tumors. It may help doctors better understand your tumor without extra procedures.
This study uses advanced imaging (ultrasound with contrast dye and MRI) combined with artificial intelligence to help doctors plan the best surgery for early-stage liver cancer. The goal is to improve treatment outcomes and help doctors choose between two surgical options: removing part of the liver or using heat to destroy the tumor.
This study looks at how well different combinations of interventional procedures (like TACE) and systemic treatments (like targeted therapy or immunotherapy) work for liver cancer. It uses real-world data to find which combinations might be best for different patients.
This study tracks how bile duct and liver cancers change during treatment, to help doctors find the best therapies for patients. It is for people who are newly diagnosed or starting a new treatment.
This trial uses special MRI scans to learn more about liver cancer (hepatocellular carcinoma) before and during treatment with TACE or SIRT. It may help doctors better understand how the tumor responds to therapy.
This trial tests a new imaging technique that uses a special dye combined with a chemotherapy drug to help surgeons see and remove liver cancer more precisely during surgery. It is for people with a first-time, single liver tumor that is small and can be surgically removed.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.